NF-kappaB Inhibition Resolves Cognitive Deficits in Experimental Type 2 Diabetes Mellitus through CREB and Glutamate/GABA Neurotransmitters Pathway.
Diabetes is associated with deficits in memory and cognitive functions and sustained inflammation. Recently, involvement of NF-kappaB (nuclear factor kappa-light-chain-enhancer of activated B cells) has been postulated in many cognitive functions, immune .....